Skip to content

A study based on the effect of ileal prophylactic ostomy patients on the brain-gut axis

A study based on the effect of ileal prophylactic ostomy patients on the brain-gut axis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065716
Enrollment
Unknown
Registered
2022-11-13
Start date
2022-11-14
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low rectal cancer

Interventions

case series:None

Sponsors

Second Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years; 2. The patient was diagnosed with low rectal cancer for the first time, and planned to undergo radical resection of stage I rectal cancer (Dixon) combined with preventive ileostomy operation plus ileostomy reduction six months later; 3. The patient was diagnosed with rectal cancer without chemotherapy, radiotherapy and immunotherapy; 4. The patient had no obvious dietary preference; 5. No history of other digestive tract diseases (except intestinal polyps and gallstones); 6. Willing to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Multiple tumors were considered in preoperative examination; 2. The patient has other infectious diseases or autoimmune diseases; 3. Patients have congenital or acquired metabolic diseases; 4. Took antibiotics 1 month before being included in the study; 5. The surgical plan was changed. Ileostomy was not performed in stage I surgery; 6. Due to some reasons, the patient did not perform ostomy restoration; 7. The patient developed tumor progression before surgery; 8. Life expectancy < 1 year; 9. Terminal stage of tumor; 10. Cerebrovascular diseases, neurodegenerative diseases, epilepsy, mental diseases, brain tumors, anorexia, pica, uncontrollable obesity, and other diseases affecting eating; 11. The body contains metal implants, not suitable for brain MRI patients.

Design outcomes

Primary

MeasureTime frame
Plasma nontarget metabonomics;Gastrin;Glucagon like peptide-1;5-hydroxytryptamine;Faeces metagenome;Faeces 16srRNA;Faeces metabolomics;Cognitive ability;Anxiety;Depression;Stress;Appetite and food intake;Dietary structure;

Countries

China

Contacts

Public ContactQiu Yuan

Second Affiliated Hospital of Army Medical University, PLA

xiaoq2037@qq.com+86 13629762037

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026